Librarian Capital's Research Library

Librarian Capital's Research Library

Share this post

Librarian Capital's Research Library
Librarian Capital's Research Library
Unilever: Q3 Still Distorted By COVID; Be Patient With 3.7% Dividend Yield

Unilever: Q3 Still Distorted By COVID; Be Patient With 3.7% Dividend Yield

(Preview) Company Update (ULVR LN) (Buy)

Librarian Capital's avatar
Librarian Capital
Nov 22, 2021
∙ Paid

Share this post

Librarian Capital's Research Library
Librarian Capital's Research Library
Unilever: Q3 Still Distorted By COVID; Be Patient With 3.7% Dividend Yield
Share

Summary

  • Q3 was again driven by COVID-related factors, impacting different categories differently; regional sales growth varied due to mix.

  • Inflation increased in Q3, and more price hikes were implemented as a partial offset; full-year EBIT margin is expected to be "around flat"

  • There are tentative signs of improving competitiveness, including in the U.S.; sales growth continued to be strong in India and China.

  • The Tea business was sold for €4.5bn, with proceeds likely to be used to fund buybacks worth 3%+ of the current market capitalization.

  • With shares at 3,900p, we expect annualized returns to be in the 12-17% range, an attractive risk/reward. The Dividend Yield is 3.7%. Buy.

Introduction

We review our Unilever PLC investment case, following the Q3 trading update on October 21 and the sale of the Tea business on November 18.

We initiated our Buy rating on Unilever in December 2020. Since then Unilever shares in London have lost 9.2% (after dividends) in GBP.

Unilever has continued to be neg…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Librarian Capital
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share